Ionis Pharmaceuticals EBITDA Margin 2010-2024 | IONS

Ionis Pharmaceuticals ebitda margin for the quarter ending September 30, 2024 was -47.07%.

  • Ionis Pharmaceuticals average ebitda margin for 2023 was -70.53%, a 491.69% decline from 2022.
  • Ionis Pharmaceuticals average ebitda margin for 2022 was -11.92%, a 43.4% increase from 2021.
  • Ionis Pharmaceuticals average ebitda margin for 2021 was -21.06%, a 389.68% decline from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

Ionis Pharmaceuticals EBITDA Margin 2010-2024 | IONS

  • Ionis Pharmaceuticals average ebitda margin for 2023 was -70.53%, a 491.69% decline from 2022.
  • Ionis Pharmaceuticals average ebitda margin for 2022 was -11.92%, a 43.4% increase from 2021.
  • Ionis Pharmaceuticals average ebitda margin for 2021 was -21.06%, a 389.68% decline from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.